Bepridil

Bepridil
Systematic (IUPAC) name
N-benzyl-N-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline
Clinical data
Trade names Vascor
AHFS/Drugs.com monograph
MedlinePlus a699051
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Oral
Pharmacokinetic data
Bioavailability Well absorbed
Protein binding 99%
Metabolism Hepatic, CYP3A4-mediated
Biological half-life 42 hours
Excretion Renal
Identifiers
CAS Number 64706-54-3 YesY
ATC code C08EA02 (WHO)
PubChem CID 2351
IUPHAR/BPS 2337
DrugBank DB01244 YesY
ChemSpider 2261 YesY
UNII 755BO701MA YesY
ChEBI CHEBI:3061 YesY
ChEMBL CHEMBL1008 YesY
Chemical data
Formula C24H34N2O
Molar mass 366.54 g/mol
  (verify)

Bepridil (trade name Vascor) is an amine calcium channel blocker once used to treat angina. It is no longer sold in the United States.

It is nonselective.[1]

It has been discussed as a possible option in the treatment of atrial fibrillation.[2]

It has been implicated in causing ventricular arrhythmia (torsades de pointes).

Ebola research

In June 2015 a research paper [3] was published finding bepridil to result in a 100% survival rate for mice exposed to ebola during an experiment searching for potential pharmaceutical ebola treatments; indicating its potential use in future ebola research and therapy.[4]

References

External links


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.